Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Anke
    Junior Member
    • Jun 2015
    • 4

    #1

    My Sanger sequencing results do not fit to RNA seq

    Hi everyone,

    I am having troubles with proofing the results I obtained in Sanger sequencing by other methods.
    At the beginning of my PhD I isolated RNA of human cancer cells, transcribed it into cDNA and amplified my gene of interest. I cloned it into the TOPO vector and transformed everything into TG1 cells. the DNA of the different clones was then checked by Sanger and I came up with several different versions of the protein. I repeated this quite often, I sequenced forward and reverse, I sequenced the PCR product directly and I used different polymerases and I always found these versions. I was also able to proof their existence with qRT-PCR and on protein level ( western+MALDI).
    I then isolated DNA and came up with WT sequences. So we assumed that alternative splicing must take place.
    My problem however is that so far any other sequencing method can' t repeat these results. I tried pyrosequencing, which didin ' t work for somehow the primers couldn't bind or for any other reason. Anyway pyrosequencing didn't give me sequences not even WT. I tried to use LNAs but I couldn't get the LNAs to differ between WT and "mutated" version. I tried digital droplet PCR which didn't work either. In the end we also performed RNA seq. The site of interest was only mapped by 3% however no mutated form was found.
    We assume that the site of interest has a quite difficult struture and maybe hard to access but still this is really confusing. We already talked to several splicing experts however so far nobody has explanation for what mechanism might take place.
    Is anyone having ideas how to explain these controversing data and how to proof the existence by any other method apart from Sanger? ??????????????

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
24 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
68 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...